Organization
Medical Oncology Department, Catalan Institute of Oncology (ICO), L'hospitalet De Llobregat, Spain
1 abstract
Abstract
Effects of neutralization of tumor-derived immunosuppressant GDF-15 on anti-PD-1 activity in anti-PD-(L)1 relapsed/refractory non-squamous NSCLC, urothelial, and hepatocellular cancer.Org: University of Navarra Clinic, Pamplona, Spain, START-CIOCC Hospital Universitario HM Sanchinarro, Madrid, Spain, Medical Oncology Department, Catalan Institute of Oncology (ICO), L'hospitalet De Llobregat, Spain, Department of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland, Department of Hematology/Oncology, University of Wuerzburg, Wuerzburg, Germany,